RNA-guided human genome engineering
A method of altering a eukaryotic cell is provided including transfecting the eukaryotic cell with a nucleic acid encoding RNA complementary to genomic DNA of the eukaryotic cell, transfecting the eukaryotic cell with a nucleic acid encoding an enzyme that interacts with the RNA and cleaves the genomic DNA in a site specific manner, wherein the cell expresses the RNA and the enzyme, the RNA binds to complementary genomic DNA and the enzyme cleaves the genomic DNA in a site specific manner.
1. A method of altering a eukaryotic cell comprising
providing to the eukaryotic cell guide RNA sequences complementary to target nucleic acid sequences,
providing to the cell a Cas9 protein having inactive nuclease domains that interacts with the guide RNA sequence and binds to the target nucleic acid sequences in a site specific manner,
wherein the Cas 9 has a FokI nuclease domain attached thereto,
wherein a target nucleic acid sequence is cleaved upon FokI nuclease domain dimerization of adjacent guide RNA sequence and Cas9 protein co-localization complexes.
2. The method of claim 1
wherein the guide RNA is provided to the cell by introducing to the cell a nucleic acid encoding the guide RNA,
wherein the Cas9 protein having the FokI nuclease domain is provided to the cell by introducing to the cell a nucleic acid encoding the Cas9 protein having the FokI nuclease domain, and
wherein the cell expresses the guide RNA and the Cas9 protein having the FokI nuclease domain.
3. The method of claim 1 wherein the eukaryotic cell is a yeast cell, a plant cell or a mammalian cell.
4. The method or claim 1 wherein the eukaryotic cell is a human cell.
5. The method of claim 1 wherein the guide RNA is between about 10 to about 250 nucleotides.
6. The method of claim 1 wherein the guide RNA is between about 20 to about 100 nucleotides.
7. The method of claim 1 wherein the guide RNA is between about 100 to about 250 nucleotides.